4.6 Review

FOXK2 Transcription Factor and Its Emerging Roles in Cancer

Journal

CANCERS
Volume 11, Issue 3, Pages -

Publisher

MDPI
DOI: 10.3390/cancers11030393

Keywords

FOXK2 transcription factor; forkhead box; transcriptional activity; cancer

Categories

Funding

  1. L'oreal-ABC-UNESCO Para Mulheres na Ciencia: N/A

Ask authors/readers for more resources

Forkhead box (FOX) transcription factors compose a large family of regulators of key biological processes within a cell. FOXK2 is a member of FOX family, whose biological functions remain relatively unexplored, despite its description in the early nineties. More recently, growing evidence has been pointing towards a role of FOXK2 in cancer, which is likely to be context-dependent and tumour-specific. Here, we provide an overview of important aspects concerning the mechanisms of regulation of FOXK2 expression and function, as well as its complex interactions at the chromatin level, which orchestrate how it differentially regulates the expression of gene targets in pathophysiology. Particularly, we explore the emerging functions of FOXK2 as a regulator of a broad range of cancer features, such as cell proliferation and survival, DNA damage, metabolism, migration, invasion and metastasis. Finally, we discuss the prognostic value of assessing FOXK2 expression in cancer patients and how it can be potentially targeted for future anticancer interventions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Expression of nuclear XIAP associates with cell growth and drug resistance and confers poor prognosis in breast cancer

Deborah Delbue, Bruna S. Mendonca, Marcela C. Robaina, Lauana G. T. Lemos, Pedro Lucena, Joao P. B. Viola, Lidia M. Magalhaes, Susanne Crocamo, Caio A. B. Oliveira, Felipe R. Teixeira, Raquel C. Maia, Gabriela Nestal de Moraes

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)

Article Cell Biology

ADO/hypotaurine: a novel metabolic pathway contributing to glioblastoma development

Dachuan Shen, Lili Tian, Fangyu Yang, Jun Li, Xiaodong Li, Yiqun Yao, Eric W. -F. Lam, Peng Gao, Bilian Jin, Ruoyu Wang

Summary: The ADO/hypotaurine axis plays a crucial role in driving the self-renewal and maintenance of glioma 'cancer stem cells' or glioma cancer stem-like cells. Inhibiting this metabolic pathway may limit glioblastoma cell proliferation and tumor growth.

CELL DEATH DISCOVERY (2021)

Review Oncology

Update on drug transporter proteins in acute myeloid leukemia: Pathological implication and clinical setting

Flavia Cunha Vasconcelos, Paloma Silva de Souza, Thais Hancio, Fernanda Costas Casal de Faria, Raquel Ciuvalschi Maia

Summary: Acute myeloid leukemia (AML) is a common hematological neoplasia with unsatisfactory long-term overall survival, possibly due to factors such as older age, genetic heterogeneity, and molecular characteristics. The expression of ABCB1, ABCC1, ABCG2, and LRP transporter proteins is considered a major reason for multidrug resistance in AML, but conflicting data exist.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)

Article Oncology

Altered Serum Metabolic Profile Assessed by Advanced 1H-NMR in Breast Cancer Patients

Josep Guma, Jose Adria-Cebrian, Belen Ruiz-Aguado, Cinta Albacar, Josefa Girona, Ricardo Rodriguez-Calvo, Neus Martinez-Micaelo, Eric W. F. Lam, Luis Masana, Sandra Guaita-Esteruelas

Summary: The study identified a positive association between TG-enriched particles and certain branched amino acids with breast cancer, suggesting a distinct metabolic signature in BC patients that could aid in improved stratification and treatment. This is the first time advanced NMR profiling has been used to identify relevant lipid and amino acid metabolites in BC serum samples for early and reliable diagnosis and prognosis.

CANCERS (2021)

Article Multidisciplinary Sciences

Cancer cell immune mimicry delineates onco-immunologic modulation

Rui Gao, He Bin, Qitao Huang, Zifeng Wang, Min Yan, Eric Wing-Fai Lam, Suxia Lin, Bo Wang, Quentin Liu

Summary: The presence of immune transcripts in cancer cells increases during malignant transformation, contributing to different prognoses of immune gene signatures. An optimized immune response signature, obtained by excluding cancer-related immune genes, offers more reliable prognostic value and reveals favorable associations with antigen presentation, NK cell killing, and T cell signaling. Higher expression of this signature is associated with better responses to immunotherapy and predicts favorable prognosis, providing insights into cancer cell plasticity and the tumor microenvironment.

ISCIENCE (2021)

Article Dentistry, Oral Surgery & Medicine

Primary diffuse large B-cell lymphoma of the head and neck in a Brazilian single-center study

Paula Sabbo Bernardo, Thais Hancio, Flavia da Cunha Vasconcelos, Gabriela Nestal de Moraes, Ricardo de Sa Bigni, Luciana Wernersbach Pinto, Luiz Claudio Santos Thuler, Raquel Ciuvalschi Maia

Summary: This retrospective study in a Brazilian cancer center aimed to investigate the characteristics and survival rates of head and neck diffuse large B-cell lymphoma (DLBCL) patients. The study found that DLBCL was more common in middle-aged and elderly male patients, with Waldeyer's ring being the most common primary tumor location. Older age, male gender, high LDH levels, and HIV positivity were associated with shorter overall survival rates and increased risk of death. Treatment was identified as the only protective factor, improving overall survival and reducing risk of death. However, the combination of chemotherapy and radiotherapy did not show any additional benefits compared to isolated treatment modalities.

ORAL DISEASES (2023)

Article Oncology

USMB-shMincle: a virus-free gene therapy for blocking M1/M2 polarization of tumor-associated macrophages

Vivian Weiwen Xue, Jeff Yat-Fai Chung, Philip Chiu-Tsun Tang, Alex Siu-Wing Chan, Travis Hoi-Wai To, Justin Shing-Yin Chung, Francis Mussal, Eric W-F Lam, Chunjie Li, Ka-Fai To, Kam-Tong Leung, Hui-Yao Lan, Patrick Ming-Kuen Tang

Summary: The study demonstrates the development of a novel gene therapeutic approach targeting Mincle in a tumor-specific manner using the USMB system. The strategy effectively inhibits protumoral effects in mouse and human macrophages, showing potential for clinical translation in cancer treatment.

MOLECULAR THERAPY-ONCOLYTICS (2021)

Article Oncology

MCF-7 Drug Resistant Cell Lines Switch Their Lipid Metabolism to Triple Negative Breast Cancer Signature

Jose Adria-Cebrian, Sandra Guaita-Esteruelas, Eric W. -F. Lam, Marta Rodriguez-Balada, Jordi Capellades, Josefa Girona, Ana Maria Jimenez-Santamaria, Oscar Yanes, Luis Masana, Josep Guma

Summary: This study demonstrates the importance of tumor microenvironment crosstalk, the crucial role of lipid transfer between adipose tissue and cancer cells, and the specific lipid signature of each breast cancer subtype. Different breast cancer cell lines metabolize lipids in different ways, with drug resistant cells showing a metabolic pattern more similar to triple negative breast cancer cells. Understanding these lipid patterns may be helpful in breast cancer diagnosis and developing targeted treatments.

CANCERS (2021)

Article Biochemistry & Molecular Biology

Targeting epiregulin in the treatment-damaged tumor microenvironment restrains therapeutic resistance

Changxu Wang, Qilai Long, Qiang Fu, Qixia Xu, Da Fu, Yan Li, Libin Gao, Jianming Guo, Xiaoling Zhang, Eric W-F Lam, Judith Campisi, Yu Sun

Summary: The soluble factor EREG, produced by senescent stromal cells, plays a crucial role in the development and malignant progression of cancer cells in the tumor microenvironment. Targeting EREG in treatment-damaged TME significantly improves cancer therapeutic efficacy and shows potential value in translational medicine.

ONCOGENE (2022)

Article Multidisciplinary Sciences

Single-cell RNA sequencing uncovers a neuron-like macrophage subset associated with cancer pain

Philip Chiu-Tsun Tang, Jeff Yat-Fai Chung, Jinyue Liao, Max Kam-Kwan Chan, Alex Siu-Wing Chan, Guangyao Cheng, Chunjie Li, Xiao-Ru Huang, Calvin Sze -Hang Ng, Eric W. -F Lam, Dongmei Zhang, Yi-Ping Ho, Ka-Fai To, Kam -Tong Leung, Xiaohua Jiang, Ho Ko, Tin -Lap Lee, Hui-Yao Lan, Patrick Ming-Kuen Tang

Summary: This study discovered a direct mechanism of tumor-associated macrophage (TAM) for promoting de novo neurogenesis, which contributes to a better understanding of tumor innervation. The study also identified a phenomenon of macrophage to neuron-like cell transition (MNT) and identified a crucial regulator for MNT. This finding has potential clinical significance for the treatment of cancer pain.

SCIENCE ADVANCES (2022)

Article Multidisciplinary Sciences

High expression of cytoplasmic FOXO3 protein associated with poor prognosis of rectal cancer patients: A study from Swedish clinical trial of preoperative radiotherapy to big database analysis

Weiyingqi Cui, Ning Xie, Eric W. -F. Lam, Victoria Hahn-Stromberg, Na Liu, Hong Zhang, Xiao-Feng Sun

Summary: Accumulating evidence suggests the important roles of FOXO3, FOXM1, and SIRT6 in cancer progression. This study investigates the expression and clinical significance of these proteins in rectal cancer patients undergoing radiotherapy (RT). The results show that FOXO3 and FOXM1 are mainly expressed in the cytoplasm, while SIRT6 is expressed in both the cytoplasm and nucleus. FOXO3 expression increases with tumor progression, while SIRT6 expression decreases. High FOXO3 expression is associated with late TNM stage, distant metastasis, and poor prognosis in RT patients. Genetic analysis implicates DNA methylation in FOXO3 overexpression. Functional enrichment analysis reveals the involvement of FOXO3 in metabolism-related signaling pathways and radioresistance. In conclusion, FOXO3 may serve as a prognostic factor in rectal cancer patients undergoing RT.

HELIYON (2023)

Article Multidisciplinary Sciences

Crosstalk between biological and chemical diversity with cytotoxic and cytostatic effects of Aphanothece halophytica in vitro

Isabel V. G. Silva, Karina L. Silva, Raquel C. Maia, Heitor M. Duarte, Ricardo Coutinho, Maria Helena C. B. Neves, Angelica R. Soares, Giselle P. F. Lopes

Summary: Different solvent extracts from Aphanothece halophytica were tested for their cytotoxic effects on human cancer cells. The extracts containing 100% and 90% A. halophytica showed significant cytotoxic effects on human breast cancer cells. The extracts also demonstrated cytostatic effects on breast cancer cells and glioblastoma cells, causing cell cycle arrest in the S phase. The chemical composition of the extracts varied depending on the abundance of A. halophytica, with fatty acids, hydrocarbons, and phthalates being predominant. This suggests that A. halophytica could be a valuable source of novel anticancer compounds.

ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2022)

Review Biotechnology & Applied Microbiology

Therapeutic strategies targeting FOXO transcription factors

Giampaolo Calissi, Eric W. -F. Lam, Wolfgang Link

Summary: FOXO proteins are transcription factors that are involved in regulating stress responses to maintain cellular homeostasis. Dysregulation of FOXO protein functions contributes to cardiovascular disease, cancer, diabetes, and neurological diseases. This review summarizes the biology of FOXO proteins, their roles in disease and longevity, and discusses pharmacological approaches to develop FOXO-targeting therapeutics.

NATURE REVIEWS DRUG DISCOVERY (2021)

No Data Available